Large breast size as a risk factor for late adverse effects of breast radiotherapy: Is residual dose inhomogeneity, despite 3D treatment planning and delivery, the main explanation?-Reference-Cited by-同舟云学术

Large breast size as a risk factor for late adverse effects of breast radiotherapy: Is residual dose inhomogeneity, despite 3D treatment planning and delivery, the main explanation?

Published:2011-08 Issue:2 Volume:100 Page:236-240
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Goldsmith Christy,Haviland Joanne,Tsang Yat,Sydenham Mark,Yarnold John

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference32 articles.

1. The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity;Moody;Radiother Oncol,1994

2. The influence of breast size on late radiation reaction following excision and radiotherapy for early breast cancer;Brierley;Clin Oncol (R Coll Radiol),1991

3. Analysis of cosmetic results and complications in patients with stage I and II breast cancer treated by biopsy and irradiation;Clarke;Int J Radiat Oncol Biol Phys,1983

4. Primary breast irradiation in large-breasted or heavy women: analysis of cosmetic outcome;Gray;Int J Radiat Oncol Biol Phys,1991

5. Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast;Harris;Int J Radiat Oncol Biol Phys,1979

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uptake of ultra-hypofractionated radiation therapy following breast-conserving surgery among patients with early-stage breast cancer: a multi-institutional questionnaire survey;Breast Cancer;2024-07-24

2. Uptake of ultra-hypofractionated radiation therapy following breast conserving surgery among patients with early-stage breast cancer: A multi-institutional questionnaire survey;2024-05-13

3. Factors predicting Cosmesis (CA), Late effects (LE) and Patient reported outcome measures (PROM) in high-risk breast cancer (BC) treated with hypo-fractionated radiotherapy (HF-WBI): real world outcomes from a developing country;2024-01-08

4. Obesity-associated changes in molecular biology of primary breast cancer;Nature Communications;2023-07-21

5. Comparative dosimetric and radiobiological assessment of left-sided whole breast and regional nodes with advanced radiotherapy techniques;Journal of Radiation Research;2023-06-14